What does Cyclo Therapeutics, Inc. do?

Jun 22 2025 06:07 PM IST
share
Share Via
Cyclo Therapeutics, Inc. is a micro-cap biotechnology company with recent net sales of $0 million and a net loss of $4 million. It has a market cap of $20.73 million and key metrics indicating it is currently loss-making with no dividend yield.
Overview:
Cyclo Therapeutics, Inc. operates in the biotechnology industry and is classified as a micro-cap company. Financial Snapshot: Most recent Net Sales: 0 Million (Quarterly Results - Dec 2024) Most recent Net Profit: -4 Million (Quarterly Results - Dec 2024) Market-cap: USD 20.73 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: -0.85 Return on Equity: 159.14% Price to Book: -1.40 Contact Details: Details: No Company Details Available Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is Cyclo Therapeutics, Inc.?
Jun 22 2025 05:36 PM IST
share
Share Via